0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Original Investigation |

Impact of Screening Colonoscopy on Outcomes in Colon Cancer Surgery

Ramzi Amri, MSc1; Liliana G. Bordeianou, MD1; Patricia Sylla, MD1; David L. Berger, MD1
[+] Author Affiliations
1Division of General and Gastrointestinal Surgery, Massachusetts General Hospital and Harvard Medical School, Boston
JAMA Surg. 2013;148(8):747-754. doi:10.1001/jamasurg.2013.8.
Text Size: A A A
Published online

Importance  Screening colonoscopy seemingly decreases colorectal cancer rates in the United States. In addition to removing benign lesions and preventing progression to malignancy, screening colonoscopy theoretically identifies asymptomatic patients with early-stage disease, potentially leading to higher survival rates.

Objectives  To assess the effect of screening colonoscopy on outcomes of colon cancer surgery by reviewing differences in staging, disease-free interval, risk of recurrence, and survival and to identify whether diagnosis through screening improves long-term outcomes independent of staging.

Design  Retrospective review of prospectively maintained, institutional review board–approved database.

Setting  Tertiary care center with high patient volume.

Patients  All patients who underwent colon cancer surgery at Massachusetts General Hospital from January 1, 2004, through December 31, 2011.

Intervention  Colon cancer surgery.

Main Outcomes and Measures  Postoperative staging, death, and recurrence, measured as incidence and time to event.

Results  A total of 1071 patients were included, with 217 diagnosed through screening. Patients not diagnosed through screening were at risk for a more invasive tumor (≥T3: relative risk [RR] = 1.96; P < .001), nodal disease (RR = 1.92; P < .001), and metastatic disease on presentation (RR = 3.37; P < .001). In follow-up, these patients had higher death rates (RR = 3.02; P < .001) and recurrence rates (RR = 2.19; P = .004) as well as shorter survival (P < .001) and disease-free intervals (P < .001). Cox and logistic regression controlling for staging and baseline characteristics revealed that death rate (P = .02) and survival duration (P = .01) were better stage for stage with diagnosis through screening. Death and metastasis rates also remained significantly lower in tumors without nodal or metastatic spread (all P < .001).

Conclusions and Relevance  Patients with colon cancer identified on screening colonoscopy not only have lower-stage disease on presentation but also have better outcomes independent of their staging. Compliance to screening colonoscopy guidelines can play an important role in prolonging longevity, improving quality of life, and reducing health care costs through early detection of colon cancer.

Figures in this Article

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Place holder to copy figure label and caption
Figure 1.
Distribution of Staging

The distributions are shown according to T stage (A), N stage (B), and M stage (C).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Kaplan-Meier Curves for Survival and Disease-Free Interval

Kaplan-Meier curves for survival (A) and disease-free interval (B).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.
Kaplan-Meier Curves Displaying Stage-for-Stage Outcomes for Survival and Disease-Free Survival Divided by Screening and Nonscreening Groups

Survival is shown for T stage (A), N stage (C), and M stage (E), and disease-free survival is shown for T stage (B), N stage (D), and M stage (F).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 4.
Multivariate Cox Proportional Hazards Curves

The cumulative hazard (A) and cumulative survival (B) are shown for disease-free interval, and the cumulative hazard (C) and cumulative survival (D) are shown for survival. The multivariate Cox proportional hazards curves control for T stage, N stage, metastatic presentation, and age at surgery.

Graphic Jump Location

Tables

References

Correspondence

CME


You need to register in order to view this quiz.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 3

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
Jobs
JAMAevidence.com

Users' Guides to the Medical Literature
Clinical Resolution

Users' Guides to the Medical Literature
Adverse effects of colonoscopy are one of the main risks of CRC screening. Data from the UK trial...

brightcove.createExperiences();